Acknowledgement
Supported by : National Research Foundation of Korea (NRF), WCSL (World Class Smart Lab)
References
- Usuda J, Kato H, Okunaka T, Furukawa K, Tsutsui H, Yamada K, et al. Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol. 2006;1:489-93. https://doi.org/10.1016/S1556-0864(15)31616-6
- Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380-7. https://doi.org/10.1038/nrc1071
- Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497-508. https://doi.org/10.1016/S1470-2045(04)01529-3
- Pandey RK, Goswami LN, Chen Y, Gryshuk A, Missert JR, Oseroff A, et al. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers Surg Med. 2006;38:445-67. https://doi.org/10.1002/lsm.20352
- Leman JA, Morton CA. Photodynamic therapy: applications in dermatology. Expert Opin Biol Ther. 2002;2:45-53. https://doi.org/10.1517/14712598.2.1.45
- Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of ophthalmology. Ophthalmology. 2000;107:2314-7. https://doi.org/10.1016/S0161-6420(00)00562-5
- Rubio N, Rajadurai A, Held KD, Prise KM, Liber HL, Redmond RW. Real-time imaging of novel spatial and temporal responses to photodynamic stress. Free Radic Biol Med. 2009;47:283-90. https://doi.org/10.1016/j.freeradbiomed.2009.04.024
- Kolarova H, Nevrelova P, Tomankova K, Kolar P, Bajgar R, Mosinger J. Production of reactive oxygen species after photodynamic therapy by porphyrin sensitizers. Gen Physiol Biophy. 2008;27:101-5.
- Daniell MD, Hill JS. A history of photodynamic therapy. Aust N Z J Surg. 1991;61:340-8. https://doi.org/10.1111/j.1445-2197.1991.tb00230.x
- Kou J, Dou D, Yang L. Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget. 2017;8:81591-603.
- Evensen JF. The use of porphyrins and non-ionizing radiation for treatment of cancer. Acta Oncol. 1995;34:1103-10. https://doi.org/10.3109/02841869509127237
- Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol. 1976;115:150-1. https://doi.org/10.1016/S0022-5347(17)59108-9
- Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1982;81:269-77. https://doi.org/10.1378/chest.81.3.269
- Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628-35.
- Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther. 2004;1:279-93. https://doi.org/10.1016/S1572-1000(05)00007-4
- Vileno B, Sienkiewicz A, Lekka M, Kulik AJ, Forro L. In vitro assay of singlet oxygen generation in the presence of water-soluble derivatives of C60. Carbon. 2004;42:1195-8. https://doi.org/10.1016/j.carbon.2003.12.042
- Foote CS. Mechanisms of photosensitized oxidation. Science. 1968;162:963-70. https://doi.org/10.1126/science.162.3857.963
- Vaupel P, Hockel M, Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 2007;9:1221-35. https://doi.org/10.1089/ars.2007.1628
- Nordsmark M, Bentzen SM, Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol. 1994;33:383-9. https://doi.org/10.3109/02841869409098433
- Cui J, Mao X, Olman V, Hastings PJ, Xu Y. Hypoxia and miscoupling between reduced energy efficiency and signaling to cell proliferation drive cancer to grow increasingly faster. J Mol Cell Biol. 2012;4:174-6. https://doi.org/10.1093/jmcb/mjs017
- McKeown SR. Defining normoxia, physoxia and hypoxia in tumoursimplications for treatment response. Br J Radiol. 2014;87:20130676. https://doi.org/10.1259/bjr.20130676
- Meuthen D, Rick IP, Thunken T, Baldauf SA. Visual prey detection by nearinfrared cues in a fish. Die Naturwissenschaften. 2012;99:1063-6. https://doi.org/10.1007/s00114-012-0980-7
- Keereweer S, Van Driel PB, Robinson DJ, Lowik CW. Shifting focus in optical image-guided cancer therapy. Mol Imaging Biol 2014; 16:1-9. https://doi.org/10.1007/s11307-013-0688-x
- Rasmussen-Taxdal DS, Ward GE, Figge FH. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Surg Forum. 1955;5:619-24.
- Allison RR, Bagnato VS, Cuenca R, Downie GH, Sibata CH. The future of photodynamic therapy in oncology. Future Oncol. 2006;2:53-71. https://doi.org/10.2217/14796694.2.1.53
- Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Dougherty TJ. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Lasers Surg Med. 2006;38:439-44. https://doi.org/10.1002/lsm.20340
- Reynolds T. Photodynamic therapy expands its horizons. J Natl Cancer Inst. 1997;89:112-4. https://doi.org/10.1093/jnci/89.2.112
- Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagn Photodyn Ther. 2010;7:61-75. https://doi.org/10.1016/j.pdpdt.2010.02.001
- Breskey JD, Lacey SE, Vesper BJ, Paradise WA, Radosevich JA, Colvard MD. Photodynamic therapy: occupational hazards and preventative recommendations for clinical administration by healthcare providers. Photomed Laser Surg. 2013;31:398-407. https://doi.org/10.1089/pho.2013.3496
- Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med. 2001;29:305-13. https://doi.org/10.1002/lsm.1133
- Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91:441-6. https://doi.org/10.1038/sj.bjc.6601993
- Story W, Sultan AA, Bottini G, Vaz F, Lee G, Hopper C. Strategies of airway management for head and neck photo-dynamic therapy. Lasers Surg Med. 2013;45:370-6. https://doi.org/10.1002/lsm.22149
- Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50:549-57. https://doi.org/10.1136/gut.50.4.549
- Pereira SP, Ayaru L, Rogowska A, Mosse A, Hatfield AR, Bown SG. Photodynamic therapy of malignant biliary strictures using mesotetrahydroxyphenylchlorin. Eur J Gastroenterol Hepatol. 2007;19:479-85. https://doi.org/10.1097/MEG.0b013e328013c0bd
- Wyss P, Schwarz V, Dobler-Girdziunaite D, Hornung R, Walt H, Degen A, et al. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. Int J Cancer. 2001;93:720-4. https://doi.org/10.1002/ijc.1400
- Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, Emberton M, et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med. 2006;38:356-63. https://doi.org/10.1002/lsm.20275
- Nathan TR, Whitelaw DE, Chang SC, Lees WR, Ripley PM, Payne H, et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol. 2002;168:1427-32. https://doi.org/10.1016/S0022-5347(05)64466-7
- Lorenz KJ, Maier H. Photodynamic therapy with metatetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients. Eur Arch Otorhinolaryngol. 2009;266:1937-44. https://doi.org/10.1007/s00405-009-0947-2
- Patel H, Mick R, Finlay J, Zhu TC, Rickter E, Cengel KA, et al. Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res. 2008;14:4869-76. https://doi.org/10.1158/1078-0432.CCR-08-0317
- Finlay JC, Zhu TC, Dimofte A, Stripp D, Malkowicz SB, Whittington R, et al. In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy. Proc SPIE Int Soc Opt Eng. 2014;5315:132-42.
- Thomas SR, Khuntia D. Motexafin gadolinium: a promising radiation sensitizer in brain metastasis. Expert Opin Drug Discov. 2011;6:195-203. https://doi.org/10.1517/17460441.2011.546395
- Wu GN, Ford JM, Alger JR. MRI measurement of the uptake and retention of motexafin gadolinium in glioblastoma multiforme and uninvolved normal human brain. J Neuro Oncol. 2006;77:95-103. https://doi.org/10.1007/s11060-005-9101-1
- Bradley KA, Zhou T, McNall-Knapp RY, Jakacki RI, Levy AS, Vezina G, et al. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study. Int J Radiat Oncol Biol Phys. 2013;85:e55-60. https://doi.org/10.1016/j.ijrobp.2012.09.004
- Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, et al. Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's oncology group phase I study. Neuro-Oncology. 2008;10:752-8. https://doi.org/10.1215/15228517-2008-043
- Azzouzi AR, Lebdai S, Benzaghou F, Stief C. Vascular-targeted photodynamic therapy with TOOKAD(R) soluble in localized prostate cancer: standardization of the procedure. World J Urol. 2015;33:937-44. https://doi.org/10.1007/s00345-015-1535-2
- Eymerit-Morin C, Zidane M, Lebdai S, Triau S, Azzouzi AR, Rousselet MC. Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer. Virchows Arch. 2013;463:547-52. https://doi.org/10.1007/s00428-013-1454-9
- Betrouni N, Boukris S, Benzaghou F. Vascular targeted photodynamic therapy with TOOKAD(R) soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning. Lasers Med Sci. 2017;32:1301-7. https://doi.org/10.1007/s10103-017-2241-7
- Trachtenberg J, Bogaards A, Weersink RA, Haider MA, Evans A, McCluskey SA, et al. Vascular targeted photodynamic therapy with palladiumbacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol. 2007;178:1974-9. https://doi.org/10.1016/j.juro.2007.07.036
- Taneja SS, Bennett J, Coleman J, Grubb R, Andriole G, Reiter RE, et al. Final results of a phase I/II multicenter trial of WST11 vascular targeted photodynamic therapy for hemi-ablation of the prostate in men with unilateral low risk prostate Cancer performed in the United States. J Urol. 2016;196:1096-104. https://doi.org/10.1016/j.juro.2016.05.113
- Kawczyk-Krupka A, Wawrzyniec K, Musiol SK, Potempa M, Bugaj AM, Sieron A. Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy-a review. Photodiagn Photodyn Ther. 2015;12:567-74. https://doi.org/10.1016/j.pdpdt.2015.10.001
- Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, et al. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol. 2017;18:181-91. https://doi.org/10.1016/S1470-2045(16)30661-1
- Brun PH, DeGroot JL, Dickson EF, Farahani M, Pottier RH. Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy. Photochem Photobiol Sci. 2004;3:1006-10. https://doi.org/10.1039/b403534h
- Weersink RA, Forbes J, Bisland S, Trachtenberg J, Elhilali M, Brun PH, et al. Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients. Photochem Photobiol. 2005;81:106-13. https://doi.org/10.1562/2004-05-31-RA-182.1
- Kaplan MJ, Somers RG, Greenberg RH, Ackler J. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2). J Surg Oncol. 1998;67:121-5. https://doi.org/10.1002/(SICI)1096-9098(199802)67:2<121::AID-JSO9>3.0.CO;2-C
- Mang TS, Allison R, Hewson G, Snider W, Moskowitz R. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am. 1998;4:378-84.
- Tsuchihashi T, Mori K, Ueyama K, Yoneya S. Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration. Clin Ophthalmol. 2013;7:615-20.
- Pece A, Milani P, Isola V, Pierro L. A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge of chorioretinal atrophy in pathologic myopia. Ophthalmologica. 2011;225:161-8. https://doi.org/10.1159/000322362
- Huggett MT, Jermyn M, Gillams A, Illing R, Mosse S, Novelli M, et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer. 2014;110:1698-704. https://doi.org/10.1038/bjc.2014.95
- Yoshida T, Tokashiki R, Ito H, Shimizu A, Nakamura K, Hiramatsu H, et al. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration. Auris Nasus Larynx. 2008;35:545-51. https://doi.org/10.1016/j.anl.2007.10.008
- Shimizu K, Nitta M, Komori T, Maruyama T, Yasuda T, Fujii Y, et al. Intraoperative photodynamic diagnosis using Talaporfin sodium simultaneously applied for photodynamic therapy against malignant glioma: a prospective clinical study. Front Neurol. 2018;9:24. https://doi.org/10.3389/fneur.2018.00024
- Hudson R, Carcenac M, Smith K, Madden L, Clarke OJ, Pelegrin A, et al. The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer. 2005;92:1442-9. https://doi.org/10.1038/sj.bjc.6602517
- Narumi A, Tsuji T, Shinohara K, Yamazaki H, Kikuchi M, Kawaguchi S, et al. Maltotriose-conjugation to a fluorinated chlorin derivative generating a PDT photosensitizer with improved water-solubility. Org Biomol Chem. 2016;14:3608-13. https://doi.org/10.1039/C6OB00276E
- Nishie H, Kataoka H, Yano S, Kikuchi JI, Hayashi N, Narumi A, et al. A nextgeneration bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis. Oncotarget. 2016;7:74259-68.
- Staneloudi C, Smith KA, Hudson R, Malatesti N, Savoie H, Boyle RW, et al. Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer. Immunology. 2007;120:512-7. https://doi.org/10.1111/j.1365-2567.2006.02522.x
- O'Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. 2009;85:1053-74. https://doi.org/10.1111/j.1751-1097.2009.00585.x
- Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250-81. https://doi.org/10.3322/caac.20114
- Proll S, Wilhelm B, Robert B, Scheer H. Myoglobin with modified tetrapyrrole chromophores: binding specificity and photochemistry. Biochim Biophys Acta. 2006;1757:750-63. https://doi.org/10.1016/j.bbabio.2006.03.026
Cited by
- 808 nm Near-Infrared Light-Excited UCNPs@mSiO 2 -Ce6-GPC3 Nanocomposites For Photodynamic Therapy In Liver Cancer vol.14, pp.None, 2019, https://doi.org/10.2147/ijn.s221496
- Multimodal use of the porphyrin TMPyP: From cancer therapy to antimicrobial applications vol.23, pp.1, 2018, https://doi.org/10.1142/s1088424619500111
- Characterization of Perturbing Actions by Verteporfin, a Benzoporphyrin Photosensitizer, on Membrane Ionic Currents vol.7, pp.None, 2019, https://doi.org/10.3389/fchem.2019.00566
- Mitotic Catastrophe Induced in HeLa Tumor Cells by Photodynamic Therapy with Methyl-aminolevulinate vol.20, pp.5, 2018, https://doi.org/10.3390/ijms20051229
- Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer vol.11, pp.5, 2019, https://doi.org/10.3390/cancers11050597
- A Basic Study of Photodynamic Therapy with Glucose-Conjugated Chlorin e6 Using Mammary Carcinoma Xenografts vol.11, pp.5, 2019, https://doi.org/10.3390/cancers11050636
- Chlorin e6-Loaded PEG-PCL Nanoemulsion for Photodynamic Therapy and In Vivo Drug Delivery vol.20, pp.16, 2018, https://doi.org/10.3390/ijms20163958
- The Role of Photochemical Reactions in the Development of Advanced Soft Materials for Biomedical Applications vol.7, pp.16, 2018, https://doi.org/10.1002/adom.201900215
- Hyaluronic Acid-Conjugated with Hyperbranched Chlorin e6 Using Disulfide Linkage and Its Nanophotosensitizer for Enhanced Photodynamic Therapy of Cancer Cells vol.12, pp.19, 2018, https://doi.org/10.3390/ma12193080
-
Photodynamic activity of Sn(IV) meso -tetraacenaphthylporphyrin and its methyl-
$ \beta $ -cyclodextrin inclusion complexes on MCF-7 breast cancer cells vol.23, pp.11, 2019, https://doi.org/10.1142/s1088424619501633 - Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo vol.11, pp.11, 2019, https://doi.org/10.3390/cancers11111760
- Glycoconjugated Phthalocyanines as Photosensitizers for PDT – Overcoming Aggregation in Solution vol.2019, pp.42, 2019, https://doi.org/10.1002/ejoc.201901224
- Water-Soluble, Zwitterionic Poly-photosensitizers as Carrier-Free, Photosensitizer-Self-Delivery System for in Vivo Photodynamic Therapy vol.11, pp.47, 2018, https://doi.org/10.1021/acsami.9b19546
- Photophysicochemical Properties and In Vitro Phototherapeutic Effects of Iodoquinoline- and Benzothiazole-Derived Unsymmetrical Squaraine Cyanine Dyes vol.9, pp.24, 2019, https://doi.org/10.3390/app9245414
- Remodeling Tumor Microenvironment by Multifunctional Nanoassemblies for Enhanced Photodynamic Cancer Therapy vol.2, pp.None, 2018, https://doi.org/10.1021/acsmaterialslett.0c00259
- Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives vol.14, pp.None, 2018, https://doi.org/10.2147/dddt.s275007
- Multifunctional phototheranostic nanomedicine for cancer imaging and treatment vol.5, pp.None, 2018, https://doi.org/10.1016/j.mtbio.2019.100035
- Clinical application of photodynamic therapy for malignant airway tumors in China vol.11, pp.1, 2018, https://doi.org/10.1111/1759-7714.13223
- Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol vol.20, pp.None, 2018, https://doi.org/10.2174/1871520620666200415102321
- Efficient photosensitizers with aggregation-induced emission characteristics for lysosome- and Gram-positive bacteria-targeted photodynamic therapy vol.56, pp.17, 2018, https://doi.org/10.1039/d0cc00394h
- Nanomolecular singlet oxygen photosensitizers based on hemiquinonoid-resorcinarenes, the fuchsonarenes vol.11, pp.10, 2020, https://doi.org/10.1039/d0sc00651c
- Dual-Targeted Phototherapeutic Agents as Magic Bullets for Cancer vol.31, pp.3, 2018, https://doi.org/10.1021/acs.bioconjchem.9b00836
- A promising anticancer drug: a photosensitizer based on the porphyrin skeleton vol.11, pp.4, 2020, https://doi.org/10.1039/c9md00558g
- EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy vol.17, pp.4, 2020, https://doi.org/10.1021/acs.molpharmaceut.9b01280
- Conjugating biomaterials with photosensitizers: advances and perspectives for photodynamic antimicrobial chemotherapy vol.19, pp.4, 2020, https://doi.org/10.1039/c9pp00398c
- Fluorophore-Induced Plasmonic Current: Generation-Based Detection of Singlet Oxygen vol.5, pp.4, 2018, https://doi.org/10.1021/acssensors.0c00377
- In vitro photodynamic treatment of cancer cells induced by aza-BODIPYs vol.19, pp.6, 2018, https://doi.org/10.1039/d0pp00026d
- Enhanced photodynamic therapy and fluorescence imaging using gold nanorods for porphyrin delivery in a novel in vitro squamous cell carcinoma 3D model vol.8, pp.23, 2020, https://doi.org/10.1039/d0tb00810a
- NIR‐II Light Activated Photosensitizer with Aggregation‐Induced Emission for Precise and Efficient Two‐Photon Photodynamic Cancer Cell Ablation vol.30, pp.30, 2018, https://doi.org/10.1002/adfm.202002546
- Biodegradable Silica‐Based Nanoparticles with Improved and Safe Delivery of Protoporphyrin IX for the In Vivo Photodynamic Therapy of Breast Cancer vol.3, pp.7, 2018, https://doi.org/10.1002/adtp.202000022
- Nanotechnology in Modern Photodynamic Therapy of Cancer: A Review of Cellular Resistance Patterns Affecting the Therapeutic Response vol.12, pp.7, 2018, https://doi.org/10.3390/pharmaceutics12070632
- Efficient near-infrared photosensitizer with aggregation-induced emission characteristics for mitochondria-targeted and image-guided photodynamic cancer therapy vol.4, pp.7, 2020, https://doi.org/10.1039/d0qm00170h
- NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer vol.9, pp.8, 2020, https://doi.org/10.3390/jcm9082390
- Photodynamic Therapy Using a Novel Phosphorus Tetraphenylporphyrin Induces an Anticancer Effect via Bax/Bcl-xL-related Mitochondrial Apoptosis in Biliary Cancer Cells vol.53, pp.4, 2018, https://doi.org/10.1267/ahc.20-00002
- A comparative study of the photophysicochemical and photodynamic activity properties of meso -4-methylthiophenyl functionalized Sn(IV) tetraarylporphyrins and triarylcorroles vol.24, pp.9, 2018, https://doi.org/10.1142/s1088424620500273
- A comparative study of the photophysicochemical and photodynamic activity properties of meso -4-methylthiophenyl functionalized Sn(IV) tetraarylporphyrins and triarylcorroles vol.24, pp.9, 2018, https://doi.org/10.1142/s1088424620500273
- Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma vol.8, pp.9, 2020, https://doi.org/10.3390/biomedicines8090327
- Role of Photoactive Phytocompounds in Photodynamic Therapy of Cancer vol.25, pp.18, 2018, https://doi.org/10.3390/molecules25184102
- Photocytotoxicity of Oligothienyl‐Functionalized Chelates That Sensitize LnIII Luminescence and Generate 1O2 vol.26, pp.52, 2020, https://doi.org/10.1002/chem.202001568
- Synthesis and In Vitro Studies of a Gd(DOTA)-Porphyrin Conjugate for Combined MRI and Photodynamic Treatment vol.59, pp.19, 2018, https://doi.org/10.1021/acs.inorgchem.0c02189
- Strengthened Tumor Photodynamic Therapy Based on a Visible Nanoscale Covalent Organic Polymer Engineered by Microwave Assisted Synthesis vol.30, pp.45, 2018, https://doi.org/10.1002/adfm.202004834
- Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper vol.24, pp.2, 2020, https://doi.org/10.1142/s1088424620300098
- Non-Invasive Diagnostic System Based on Light for Detecting Early-Stage Oral Cancer and High-Risk Precancerous Lesions—Potential for Dentistry vol.12, pp.11, 2020, https://doi.org/10.3390/cancers12113185
- Clinical development and potential of photothermal and photodynamic therapies for cancer vol.17, pp.11, 2018, https://doi.org/10.1038/s41571-020-0410-2
- Current Targets and Bioconjugation Strategies in Photodynamic Diagnosis and Therapy of Cancer vol.25, pp.21, 2020, https://doi.org/10.3390/molecules25214964
- Daylight Photodynamic Therapy: An Update vol.25, pp.21, 2018, https://doi.org/10.3390/molecules25215195
- Photodynamic diagnosis and photodynamic therapy of colorectal cancer in vitro and in vivo vol.10, pp.68, 2018, https://doi.org/10.1039/d0ra08617g
- Polyacrylic Acid with Methylene Blue Dye as a Sensitizing Agent for Photodynamic Therapy to Reduce Streptococcus mutans in Dentinal Caries vol.38, pp.11, 2018, https://doi.org/10.1089/photob.2019.4736
- Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and Photosensitizers vol.25, pp.22, 2018, https://doi.org/10.3390/molecules25225252
- Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors vol.3, pp.1, 2018, https://doi.org/10.1038/s42003-020-0956-7
- Conjugated Photosensitizers for Imaging and PDT in Cancer Research vol.63, pp.23, 2018, https://doi.org/10.1021/acs.jmedchem.0c00047
- Azulitox-A Pseudomonas aeruginosa P28-Derived Cancer-Cell-Specific Protein Photosensitizer vol.21, pp.12, 2018, https://doi.org/10.1021/acs.biomac.0c01216
- An update in clinical utilization of photodynamic therapy for lung cancer vol.12, pp.4, 2018, https://doi.org/10.7150/jca.51537
- Stimuli‐Responsive Biomaterials: Scaffolds for Stem Cell Control vol.10, pp.1, 2021, https://doi.org/10.1002/adhm.202001125
- Recent progress in nanophotosensitizers for advanced photodynamic therapy of cancer vol.4, pp.1, 2021, https://doi.org/10.1088/2515-7639/abc9ce
- Photodynamic Therapy for the Treatment and Diagnosis of Cancer-A Review of the Current Clinical Status vol.9, pp.None, 2018, https://doi.org/10.3389/fchem.2021.686303
- Remotely Activated Nanoparticles for Anticancer Therapy vol.13, pp.1, 2018, https://doi.org/10.1007/s40820-020-00537-8
- Inorganic Nanomaterials for Photothermal‐Based Cancer Theranostics vol.4, pp.2, 2018, https://doi.org/10.1002/adtp.202000207
- Near Infrared Photo‐Antimicrobial Targeting Therapy for Candida albicans vol.4, pp.2, 2018, https://doi.org/10.1002/adtp.202000221
- Photodynamic therapy exploiting the anti-tumor activity of mannose-conjugated chlorin e6 reduced M2-like tumor-associated macrophages vol.14, pp.2, 2018, https://doi.org/10.1016/j.tranon.2020.101005
- Non-Oncologic Applications of Nanomedicine-Based Phototherapy vol.9, pp.2, 2021, https://doi.org/10.3390/biomedicines9020113
- Photodynamic Therapy Using Cerenkov and Radioluminescence Light vol.9, pp.None, 2021, https://doi.org/10.3389/fphy.2021.637120
- Glycyrrhetinic Acid-Modified Silicon Phthalocyanine for Liver Cancer-Targeted Photodynamic Therapy vol.22, pp.2, 2021, https://doi.org/10.1021/acs.biomac.0c01550
- Exploiting a Neutral BODIPY Copolymer as an Effective Agent for Photodynamic Antimicrobial Inactivation vol.125, pp.6, 2018, https://doi.org/10.1021/acs.jpcb.0c09634
- Strategies for Cancer Treatment Based on Photonic Nanomedicine vol.14, pp.6, 2018, https://doi.org/10.3390/ma14061435
- ICG/L-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissue vol.18, pp.3, 2018, https://doi.org/10.1021/acs.molpharmaceut.0c00937
- A Review of Bacteriochlorophyllides: Chemical Structures and Applications vol.26, pp.5, 2018, https://doi.org/10.3390/molecules26051293
- Phthalocyanine-Conjugated Glyconanoparticles for Chemo-photodynamic Combination Therapy vol.22, pp.4, 2018, https://doi.org/10.1021/acs.biomac.0c01811
- Magnetism, Ultrasound, and Light-Stimulated Mesoporous Silica Nanocarriers for Theranostics and Beyond vol.143, pp.16, 2021, https://doi.org/10.1021/jacs.0c10098
- Interrogating biological systems using visible-light-powered catalysis vol.5, pp.5, 2021, https://doi.org/10.1038/s41570-021-00265-6
- Effect of Cerenkov Radiation-Induced Photodynamic Therapy with 18F-FDG in an Intraperitoneal Xenograft Mouse Model of Ovarian Cancer vol.22, pp.9, 2018, https://doi.org/10.3390/ijms22094934
- Photostable Platinated Bacteriochlorins as Potent Photodynamic Agents vol.64, pp.10, 2021, https://doi.org/10.1021/acs.jmedchem.1c00052
- Features of third generation photosensitizers used in anticancer photodynamic therapy: Review vol.34, pp.None, 2021, https://doi.org/10.1016/j.pdpdt.2020.102091
- Translocator protein (TSPO)-Targeted agents for photodynamic therapy of cancer vol.34, pp.None, 2021, https://doi.org/10.1016/j.pdpdt.2021.102209
- Photo-Triggered Nanomaterials for Cancer Theranostic Applications vol.11, pp.2, 2021, https://doi.org/10.1142/s1793984421300041
- New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development vol.13, pp.12, 2018, https://doi.org/10.3390/cancers13123069
- Potential of Cyanine Derived Dyes in Photodynamic Therapy vol.13, pp.6, 2021, https://doi.org/10.3390/pharmaceutics13060818
- Supramolecular agents for combination of photodynamic therapy and other treatments vol.12, pp.21, 2018, https://doi.org/10.1039/d1sc01125a
- Photocytotoxicity of Thiophene- and Bithiophene-Dipicolinato Luminescent Lanthanide Complexes vol.64, pp.11, 2021, https://doi.org/10.1021/acs.jmedchem.0c01805
- Comparison of the Photodynamic Action of Porphyrin, Chlorin, and Isobacteriochlorin Derivatives toward a Melanotic Cell Line vol.4, pp.6, 2021, https://doi.org/10.1021/acsabm.1c00218
- Insights on the polypyrrole based nanoformulations for photodynamic therapy vol.25, pp.7, 2021, https://doi.org/10.1142/s1088424621300032
- Nanophotosensitizers for cancer therapy: a promising technology? vol.4, pp.3, 2018, https://doi.org/10.1088/2515-7639/abf7dd
- Plasmonic enhancement of nitric oxide generation vol.13, pp.28, 2018, https://doi.org/10.1039/d1nr02126e
- Micro- and Nano-Based Transdermal Delivery Systems of Photosensitizing Drugs for the Treatment of Cutaneous Malignancies vol.14, pp.8, 2018, https://doi.org/10.3390/ph14080772
- Conjugated Polymers with Aggregation‐Induced Emission Characteristics for Fluorescence Imaging and Photodynamic Therapy vol.16, pp.15, 2018, https://doi.org/10.1002/cmdc.202100138
- Photodynamic therapy using self-assembled nanogels comprising chlorin e6-bearing pullulan vol.9, pp.32, 2021, https://doi.org/10.1039/d1tb00377a
- Biodegradable Polymeric Nanoparticles Containing an Immune Checkpoint Inhibitor (aPDL1) to Locally Induce Immune Responses in the Central Nervous System vol.31, pp.38, 2018, https://doi.org/10.1002/adfm.202102274
- Pyrrole-based photosensitizers for photodynamic therapy - a Thomas Dougherty award paper vol.25, pp.9, 2018, https://doi.org/10.1142/s1088424621300044
- Photodynamic Therapy: A Compendium of Latest Reviews vol.13, pp.17, 2018, https://doi.org/10.3390/cancers13174447
- Mito‐Bomb: Targeting Mitochondria for Cancer Therapy vol.33, pp.43, 2021, https://doi.org/10.1002/adma.202007778
- Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer vol.13, pp.10, 2018, https://doi.org/10.3390/pharmaceutics13101547
- Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives vol.445, pp.None, 2018, https://doi.org/10.1016/j.ccr.2021.214104
- Antimicrobial Photodynamic Inactivation Using Topical and Superhydrophobic Sensitizer Techniques: A Perspective from Diffusion in Biofilms † vol.97, pp.6, 2018, https://doi.org/10.1111/php.13461
- Current Status of Photodynamic Diagnosis for Gastric Tumors vol.11, pp.11, 2018, https://doi.org/10.3390/diagnostics11111967
- The Importance of 6-Aminohexanoic Acid as a Hydrophobic, Flexible Structural Element vol.22, pp.22, 2018, https://doi.org/10.3390/ijms222212122
- Nanoparticle-Mediated Delivery Systems in Photodynamic Therapy of Colorectal Cancer vol.22, pp.22, 2018, https://doi.org/10.3390/ijms222212405
- Nanoformulations-based advancement in the delivery of phytopharmaceuticals for skin cancer management vol.66, pp.None, 2018, https://doi.org/10.1016/j.jddst.2021.102912
- Recent Advances in Photodynamic Therapy against Fungal Keratitis vol.13, pp.12, 2021, https://doi.org/10.3390/pharmaceutics13122011
- Silver chalcogenide nanoparticles: a review of their biomedical applications vol.13, pp.46, 2021, https://doi.org/10.1039/d0nr03872e
- Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo vol.14, pp.1, 2018, https://doi.org/10.3390/pharmaceutics14010043
- Klinische Entwicklung von Metallkomplexen als Photosensibilisatoren für die photodynamische Therapie von Krebs vol.134, pp.5, 2022, https://doi.org/10.1002/ange.202112236
- Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer vol.61, pp.5, 2018, https://doi.org/10.1002/anie.202112236